Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04087772 · ClinicalTrials.gov registry record · NA

Enhancing School-Based Violence Prevention

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
4,840
Enrollment target

NCT04087772: Completed NA study, sponsored by Medical University of South Carolina.

NCT04087772 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 4,840 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (245% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04087772, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
4,840 participants
Enrollment target

Study Summary

The purpose of this study is to compare two versions of Mental Health Enhanced Positive Behavioral Interventions and Supports in reducing aggression in middle school students.

Primary Outcome

The Reactive and Proactive Aggression Survey is a self-report instrument assessing how often the respondent has behaved aggressively towards other children over the past three months. Scores range from 0 (Never) to 5 (All of the time)

Interventions

  • BEHAVIORAL Mental Health Enhanced Positive Behavioral Interventions and Supports (PBIS-MH)
  • BEHAVIORAL Racial/Ethnic Discrimination Interventions (RED)

Trial Details

FieldValue
Enrollment Target 4,840 participants
Start Date 2019-09-13
Est. Completion 2025-12-31
Phase NA

What the finished NCT04087772 record still lists

NCT04087772 is an interventional study that assigns participants to a tested intervention. Its 4,840 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (245% higher).

The record links to 0 conditions, and to 2 interventions - of which Mental Health Enhanced Positive Behavioral Interventions and Supports (PBIS-MH) is the first listed.

NCT04087772 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04087772 about?

NCT04087772 is a clinical study titled "Enhancing School-Based Violence Prevention". The purpose of this study is to compare two versions of Mental Health Enhanced Positive Behavioral Interventions and Supports in reducing aggression in middle school students.

What is the current status of trial NCT04087772?

This trial is currently completed. It is a NA study. The enrollment target is 4,840 participants. The study started on 2019-09-13. Estimated completion is 2025-12-31.

What interventions are being tested in trial NCT04087772?

The interventions under investigation include: Mental Health Enhanced Positive Behavioral Interventions and Supports (PBIS-MH) (BEHAVIORAL), Racial/Ethnic Discrimination Interventions (RED) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04087772?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04087772's enrollment target sits among peer trials

4,840 28th of 2000 higher than 1,973 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05252754 · 4,874 participants · Phase 3

    Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

  • NCT01719055 · 4,800 participants

    RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

  • NCT05485675 · 4,800 participants · NA

    Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program

  • NCT06307652 · 4,800 participants · Phase 3

    Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04087772, the US trial registry maintained by the National Library of Medicine. NCT04087772 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.